SGAM
Smith Group Asset Management Portfolio holdings
AUM
$1.53B
1-Year Return
38.67%
This Quarter Return
+13.19%
1 Year Return
+38.67%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.04B
AUM Growth
+$154M
(+8.2%)
Cap. Flow
-$65.9M
Cap. Flow
% of AUM
-3.23%
Top 10 Holdings %
Top 10 Hldgs %
35.2%
Holding
397
New
70
Increased
71
Reduced
131
Closed
34
Top Buys
| 1 |
United Parcel Service
UPS
|
$28.3M |
| 2 |
Costco
COST
|
$27.6M |
| 3 |
KLA
KLAC
|
$25.3M |
| 4 |
IQVIA
IQV
|
$25M |
| 5 |
US Bancorp
USB
|
$22.8M |
Top Sells
| 1 |
Hologic
HOLX
|
$42.7M |
| 2 |
Eli Lilly
LLY
|
$36.4M |
| 3 |
Procter & Gamble
PG
|
$33.8M |
| 4 |
Coherent
COHR
|
$22.3M |
| 5 |
Abbott
ABT
|
$21.1M |
Sector Composition
| 1 | Technology | 31.29% |
| 2 | Consumer Discretionary | 14.43% |
| 3 | Financials | 12.78% |
| 4 | Healthcare | 12.63% |
| 5 | Industrials | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
OneMain Financial
OMF
$7.29B
| $9K | ﹤0.01% |
155
-33
| -18% | -$1.92K |
|
302
PepsiCo
PEP
$202B
| $9K | ﹤0.01% |
60
| – | – |
|
303
Qualys
QLYS
$4.87B
| $9K | ﹤0.01% |
90
| – | – |
|
304
Travelers Companies
TRV
$62B
| $9K | ﹤0.01% |
60
| – | – |
|
305
Arthur J. Gallagher & Co
AJG
$76.6B
| $8K | ﹤0.01% |
54
-11
| -17% | -$1.63K |
|
306
Duke Energy
DUK
$93.8B
| $8K | ﹤0.01% |
81
| – | – |
|
307
EQT Corp
EQT
$31.8B
| $8K | ﹤0.01% |
370
-610
| -62% | -$13.2K |
|
308
Fate Therapeutics
FATE
$113M
| $8K | ﹤0.01% |
90
| – | – |
|
309
HealthStream
HSTM
$831M
| $8K | ﹤0.01% |
270
| – | – |
|
310
Las Vegas Sands
LVS
$37B
| $8K | ﹤0.01% |
+150
| New | +$8K |
|
311
Moody's
MCO
$89.3B
| $8K | ﹤0.01% |
21
-4
| -16% | -$1.52K |
|
312
Magnolia Oil & Gas
MGY
$4.4B
| $8K | ﹤0.01% |
520
| – | – |
|
313
Progressive
PGR
$144B
| $8K | ﹤0.01% |
82
-65
| -44% | -$6.34K |
|
314
Southern Company
SO
$101B
| $8K | ﹤0.01% |
128
| – | – |
|
315
Voya Financial
VOYA
$7.39B
| $8K | ﹤0.01% |
127
-26
| -17% | -$1.64K |
|
316
Yum China
YUMC
$16.5B
| $8K | ﹤0.01% |
+120
| New | +$8K |
|
|
MRTX
317
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $8K | ﹤0.01% |
50
| – | – |
|
318
Marsh & McLennan
MMC
$100B
| $8K | ﹤0.01% |
54
-12
| -18% | -$1.78K |
|
|
319
Procter & Gamble
PG
$375B
| $8K | ﹤0.01% |
59
-248,970
| -100% | -$33.8M |
|
320
Amgen
AMGN
$152B
| $7K | ﹤0.01% |
+30
| New | +$7K |
|
321
B2Gold
BTG
$5.5B
| $7K | ﹤0.01% |
1,690
+140
| +9% | +$580 |
|
322
General Mills
GIS
$27B
| $7K | ﹤0.01% |
108
| – | – |
|
323
Halozyme
HALO
$8.61B
| $7K | ﹤0.01% |
150
| – | – |
|
324
Intercontinental Exchange
ICE
$99.8B
| $7K | ﹤0.01% |
63
-12
| -16% | -$1.33K |
|
325
Omnicom Group
OMC
$15.4B
| $7K | ﹤0.01% |
+93
| New | +$7K |
|